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INTRODUCTION
DNA, RNA, and proteins are all subjected to biochemical modifications following synthesis, which can alter and fine-tune their function by diverse regulatory mechanisms. N6-methyladenosine (m6A) is a highly prevalent base modification occurring on mammalian mRNA. Recent studies used immunoprecipitation of methylated RNA fragments followed by sequencing (m6Aseq) to globally map transcript regions enriched in m6A in mammalian cells, finding that it is strongly enriched near stop codons and in long exons (Dominissini et al., 2012; Meyer et al., 2012) .
Conceptually, m6A in mammals has the potential of fine-tuning RNA function in different ways. One possibility is that genes are subjected to methylation only under specific conditions or in specific tissues (''condition specific methylation''), as is the case in yeast meiosis (Agarwala et al., 2012; Clancy et al., 2002; Schwartz et al., 2013) . A nonmutually exclusive scenario is that m6A may mark and regulate a specific sets of transcripts (''transcript specific methylation''), for instance, by affecting their stability (Wang et al., 2014a) . To explore potential roles for m6A, it is necessary to investigate the extent to which m6A varies across physiologically relevant conditions. To date, mammalian methylated sites have been mapped and characterized in only a small number of mammalian cell lines/tissues (Dominissini et al., 2012; Meyer et al., 2012; Wang et al., 2014a) limiting the ability to evaluate methylation dynamics. Moreover, the resolution of these maps was limited, with sites typically being >20 nt away from the nearest consensus signal, potentially reflecting a nonnegligible amount of false-positives.
Obtaining accurate maps of mRNA methylation requires identification of the proteins involved in catalyzing them. We recently found in yeast that available protocols for m6a-seq identified both true methylated sites and false-positive sites, and that these two classes could be distinguished by mapping methylations that remain after knockout of the methyltransferases (Schwartz et al., 2013) . Until recently, only one protein-METTL3 (Methyl-transferase-like 3)-was implicated in m6A methylation of mammalian mRNA (Bokar et al., 1997) . However, it had been recognized that additional components were crucial for methylation (Bokar et al., 1997) . While this manuscript was under preparation, two additional proteins, WTAP and METTL14, were identified as required for methylation (Liu et al., 2014; Ping et al., 2014; Wang et al., 2014b) . These studies, however, did not study the extent to which individual sites were dependent on these proteins, which is important both to eliminate false-positives (Schwartz et al., 2013) and to identify sites that are methylated using orthogonal pathways.
Here, we have employed an unbiased proteomic approach to characterize the components of the methyltransferase complex, allowing us to identify and validate known and unknown components required for methylation. By mapping sites upon experimental depletion of these components, we were able to classify and characterize methylated sites based on their dependency on these proteins. Our analyses provide important resources at the proteomic and transcriptomic levels toward understanding the regulators (''who'') and targets (''where'') of RNA methylations, two crucial milestones toward addressing the function (''why'') of this epitranscriptomic modification.
RESULTS

Proteomic Screens Identify Components of the Methyltransferase Complex
To identify components of the human m6A methyltransferase complex, we performed coimmunoprecipitation (co-IP) experiments with an overexpressed C terminus HIS-tagged METTL3 in HEK293 cells, followed by LC-MS/MS (Experimental Procedures). After filtering out background contaminants using the CRAPOME database (Mellacheruvu et al., 2013) (Experimental Procedures) , one of the most enriched proteins was WTAP, the human ortholog of Mum2, a crucial component of the yeast methyltransferase complex (Agarwala et al., 2012; Schwartz et al., 2013) (Figure 1A ). Proteins interacting with WTAP have recently been characterized in a proteomic screen (Horiuchi et al., 2013) . Analysis of this data revealed reciprocal binding of WTAP to both METTL3 and to METTL14, a close paralog of METTL3 (Bujnicki et al., 2002) . Confirming this association, both METTL3 and WTAP were enriched when we performed mass-spectrometry following pulling down on a 3 0 terminus V5tagged version of METTL14 ( Figure 1B) . The physical association of METTL14 and WTAP with METTL3, and our previous findings that all three proteins have tightly coevolved (Schwartz et al., 2013) , thus strongly implicated them in mRNA methylation.
To explore additional proteins involved in the methylation program, we used in vitro transcribed biotinylated baits, which were either methylated or nonmethylated at a single position, to capture proteins from HEK293 protein lysates, followed by quantitative LC-MS/MS ( Figure 1C ). YTHDF1, YTHDF2, and YTHDF3, three proteins from the YTH domain family, were the top three enriched proteins in this screen. This enhances our previous results (Dominissini et al., 2012) , where two of these three proteins were identified as m6A binders (Dominissini et al., 2012) , and is consistent with recent biochemical results showing that these three proteins all selectively bind m6A (Wang et al., 2014a) . Interestingly, the fourth most enriched protein in this assay was WTAP, suggesting that WTAP may be involved not only in mediating methylation, but also in binding it.
Finally, we used a V5-tagged version of each of three YTH proteins in affinity proteomics. These experiments highlighted potential associations between different YTH proteins (e.g., between YTHDF1 and YTHDF2) or between the YTH proteins and other components of the methyltransferase machinery identified here (e.g., YTHDF2 and WTAP, YTHDF1, and METTL3). The full proteomics data sets are available in Table S1 .
Integrating the proteomic data into a network ( Figure 1D ; Experimental Procedures) highlights the centrality of WTAP and METTL14 in this complex, consistent with the three recent reports (Liu et al., 2014; Ping et al., 2014; Wang et al., 2014b) . The density and topology of the network suggest that the conceptual distinction between m6A ''writers'' and ''readers'' may not be clear cut, because the putative writers (METTL3, WTAP, METTL14) and readers (YTH proteins) may physically interact with each other. Finally, 13 proteins with diverse functions interact with two or more of the seven core components studied here and may therefore form part of the methyltransferase complex as well. However, we cannot rule out that some of these associations may be spurious, and each of these candidates will therefore have to be individually tested. Below we validate three of these proteins.
WTAP Is Necessary for m6A mRNA Methylation
To determine whether WTAP is required for mRNA methylation in vivo, we depleted it in p53 À/À mouse embryonic fibroblasts (MEFs) using WTAP-targeting small hairpin RNAs (shRNAs) to 10%-15% of WT levels (Figures S1A-S1D). We used anti-hnRPDL and anti-GFP shRNAs as negative controls. We immunoprecipitated and sequenced methylated RNA from these samples using an m6a-seq procedure, optimized for enhanced resolution and scalability using decreased starting material (Schwartz et al., 2013) . Analyzing these profiles (Experimental Procedures), we identified 16,487 putative m6A sites, present in at least two of the eight profiled conditions. Most sites (10,609/16,487, 64.3%) were WTAP dependent (''WTAP-dependent'' cluster), showing dramatically decreased methylation Peak Over Input (POI) scores compared to any of the controls (p < 2.2 3 10 À16 for all comparisons, Mann-Whitney) following knockdown with either of two shRNAs targeting different regions of WTAP (Figure 2A ). WTAP-dependent sites were strongly enriched for hallmarks of m6A methylation: sites were within a median distance of 5 nt from the nearest consensus site (Figures 2B, S1E, and S1F); 34.6% of sites were within 200 nt of the stop codon ( Figure 2C ); and median internal exons harboring sites in this cluster tended to be $7-fold longer than nonmethylated exons ( Figure 2D ).
The remaining sites formed two distinct clusters (Figure 2A ), neither of which was enriched for the methylation consensus signal (median distances to consensus motif were 27 and 38 nt, respectively), or for any of the other hallmarks of m6A methylation ( Figures 2B-2D ). One of these two clusters showed dramatic enrichment for sites near the TSS, with $50% of the sites within 200 nt of the TSS (''TSS-enriched cluster''); we show below that the sites in this cluster represent methylations on the first transcribed nucleotide as part of the cap structure. The other cluster did not exhibit such dramatic enrichment for the TSS segment but was pervasive across all sampled conditions and showed no enrichment for the m6A consensus motif.
These properties were reminiscent of a set of false-positive sites that we found in yeast when performing the same m6a-seq protocol to strains lacking a functional methyltransferase (Schwartz et al., 2013) . Indeed, sequence analysis revealed that the sites in the cluster (''false-positive cluster'') were highly enriched for the same degenerate purine-rich motif (''AGAAGAA'') that we found at the yeast false-positive sites (Figures S1G and S1H). In yeast, (C) Proteins associated with biotinylated, methylated RNA baits, compared to biotinylated, nonmethylated counterparts, in two biological replicates. (D) Network of associations with the bait proteins (shaded gray nodes) identified in the different mass-spec experiments. An edge from bait A to target B indicates that B was enriched (fold change >1.5) when performing IPs on A. Only target nodes with an incoming degree R2 are displayed. Edge width distinguishes association between baits (thick lines) and with nonbaits (thin lines). Edges are colored in dark red if they were enriched by a protein bait involving an m6a ''writer'' (METTL3/METTL14/WTAP), cyan if they were enriched by a ''reader'' (YTHDF1/YTHDF2/YTHDF3), or dark blue if they were enriched with a methylated bait. The node for KIAA1429, further analyzed functionally, is marked by a thicker border.
we have previously shown that these sites were false-positive sites enriched in a nonspecific manner during the immunoprecipitation process, because they are enriched even when we perform m6A-seq with in vitro synthesized sites without any methylations (Schwartz et al., 2013) ; thus, we considered it highly likely that these sets of sites are false-positives and conservatively opted to either analyze them separately, or eliminate them altogether, in the subsequent analyses.
We confirmed these results in human A549 cell lines where WTAP was perturbed using either shRNAs ( Figure 2E ) or siRNAs ( Figure 2F ). We observed a similarly strong reduction of methylation upon WTAP depletion in both sets of experiments, and clustering of the detected sites yielded very similar clusters to those obtained in the mouse studies above (Figures 2E and 2F) , with similar characteristics (Figures S1I-S1K).
KIAA1429 Is Required for mRNA Methylation
Of the other 13 candidates associating with methyltransferase components in our proteomics screen ( Figure 1D ), we focused our attention on KIAA1429 because its Drosophila ortholog was biochemically shown to interact with Drosophila WTAP in the context of sex-specific splicing (Ortega et al., 2003) . We used siRNAs to deplete KIAA1429 in human A549 cells to $6% of WT levels ( Figure S1C ) and performed m6A-seq on the resulting cells. We observed a median $4-fold decrease (Mann-Whitney, p < 2.2 3 10 À16 ) in peak scores compared to cells treated with nontargeting siRNAs ( Figure 2F ). Although these decreases were less dramatic than those observed upon knockdown of WTAP (median decrease: 6.25-fold), they were substantially and significantly (Mann-Whitney, p < 2.2 3 10 À16 ) more prominent than observed upon knockdown of either METTL3 or METTL14 (see below), demonstrating that KIAA1429 is required for the full methylation program in mammals.
Knockdown of METTL3 and/or METTL14 Leads to Milder Decreases in Methylation Levels
We next used shRNAs and siRNA to test the effect of depleting METTL3 and METTL14 in mouse fibroblasts (METTL3, Figure 2A ) and in human A549 cells (both, Figures 2E and 2F ). In mouse, we observed a moderate depletion of m6A levels for one of the hairpins (shMETTL3-2, where METTL3 transcript was reduced to 10% of WT levels), but not for another (shMETTL3-3, where knockdown efficiency was lower) ( Figure S1A ). In human, shRNA-mediated knockdown of METTL3 levels to $10% of WT levels did not reveal a discernible effect on m6A methylation, but use of siRNAs, which enabled even higher knockdowns ($5% of WT levels, Figures S1C and S1D), yielded POI scores that were reduced to 60% of control (Mann-Whitney, p < 2.2 3 10 À16 , Figure 2F ). Similarly, for METTL14 knockdown, we failed to observe an effect when knocking it down using shRNAs to $20% of WT levels ( Figure S1B ), but upon knocking it down to $6% with siRNAs ( Figure S1C) we observed reductions to similar levels as for METTL3 (median decrease: 51% of control). Similar levels were achieved also with dual knockdown of METTL3 and METTL14 (median decrease: 53% of control, Figure S1C). Our results, which are consistent with Liu et al. (2014) , demonstrate a strong threshold dependence for both METTL3 and METTL14, which is likely due to adequacy of even low levels of METTL3 and METTL14 to mediate mRNA methylations.
Bulk Measurements of m6A Levels Highly Consistent with m6A-Seq To further confirm our results, we used HPLC-M/S to measure bulk levels of m6A in poly(A) mRNA from A549 cells upon siRNA-mediated knockdown of the above genes ( Figure 2G ). Consistently, highest levels of depletion in m6A content in the oligo-dT selected poly(A) fraction were obtained for WTAP (5.6-fold depletion), followed by KIAA1429 ($3-fold), followed by single or combined knockdown of METTL3 and METTL14 (1.9-to 2.5-fold). M6A levels in the flowthrough fraction were roughly equal for all samples ( Figure 2G ). These results were expected, because the flowthrough is dominated by rRNA, which harbors m6A at nonconsensus positions (Liu et al., 2013; Machnicka et al., 2013) that are likely deposited by proteins distinct from the ones identified here.
A High-Quality, High-Resolution Catalog of the m6A Methylome across Four Dynamic Systems To date, mammalian methylated sites have been mapped and characterized in only a limited number of cell lines and tissues.
To determine the extent to which m6A methylation may be modulated in physiologically relevant contexts, in both mitotic and postmitotic cells, we mapped methylation across four distinct dynamic systems in human and mouse: (1) mouse bone-marrow-derived dendritic cells (BMDCs) responding to lipopolysaccharide (LPS), (2) mouse embryonic (e16) and adult brains, a system chosen based on previous reports of lower levels of bulk m6A in embryonic brain (Meyer et al., 2012) , (3) human fibroblasts undergoing reprogramming into induced pluripotent stem cells (iPSC) following doxycycline-induced expression of polycistronic OCT4-KLF4-MYC-SOX2, and (4) human embryonic stem cells undergoing differentiation into NPCs ( Figure 3A ).
Integrating all m6A profiles yielded 40,742 sites in human and 31,423 in mouse, present in at least two conditions, tripling the reported number of detected putative methylation sites compared to previous studies. We classified each site as high, intermediate, or low confidence based on a linear combination of three features: (1) number of samples in which peak was identified, (2) extent of dependency on WTAP, and (3) maximal POI score observed across any of the samples. The features were selected as informative based on distance to nearest consensus site ( Figure S2A ; Experimental Procedures), and the resulting ranking was independently consistent with enrichment of sites in long exons ( Figure S2B ) and near stop codons ( Figure S2C ). The sites identified here are at a dramatically increased resolution, compared with previous studies, with 50% of the top 15,000 sites being within 5-6 nt from the nearest consensus site, in both data sets. The full set of sites is provided (Table S2 ) allowing custom filtration of the data based on user-defined criteria.
WTAP-Dependent Sites Have a Static Topology across Multiple Dynamic Systems
Although initial examination suggested the presence of many condition-specific methylations, closer examination indicated that observed differences were largely due to changes in underlying gene expression. For example, in the mouse data set, 3,629 sites classified as ''high'' or ''intermediate'' are present only in the two brain samples, and 1,312 such sites are present exclusively in the DCs. However, these differences clearly reflected the expression levels of the genes harboring the sites ( Figures  S2D and S2E) , which indeed were enriched for genes involved in neural processes and immune response, respectively ( Figures  S2F and S2G) .
To reliably compare sites across samples despite different expression levels, we therefore conservatively limited our analysis to a subset of WTAP-dependent sites within genes expressed above the 60 th percentile in all samples, resulting in 11,247 sites in human ( Figure 3B ) and 8,456 sites in mouse (Figure 3C) . Dividing these into three equally sized sets based on their maximal POI scores across all samples, we found that among the highest scoring sites >90% of the sites in human ( Figure 3D ) and >98% of the sites in mouse ( Figure 3E ) were detected as enriched (POI >4) across all samples. Among lower scoring sites, cases of peaks being called in one condition but not in another were more common ( Figures 3D and 3E) ; however, upon manual inspection of such putative differential sites, it was difficult to identify convincing sites present in one condition and absent from another. Rather, such differences were typically due to subthreshold peaks not being called in a particular sample or insufficient coverage in a particular region. Indeed, the variability of POI scores across the different dynamic sets of conditions was similar to the variability across different experiments performed in the same cell line (MEFs in mouse, A549 in human) ( Figures S2H and S2I ). Thus, overall methylation profiles appear to be similar across diverse conditions, at least under our conservative criteria, suggesting that in mammals m6A plays a basal, ubiquitous role, shared across different cell types and systems. However, because m6A-seq cannot directly quantify methylation levels, our approach may be blind to quantitative differences in methylation levels between samples (see Discussion).
WTAP-Dependent Methylation Inversely Correlates with mRNA Stability and Is Depleted in Housekeeping Genes
Because we found little evidence for condition-specific differences in methylation, we next sought to analyze the potential of a transcript-specific role. Examining the relationship between gene-level attributes and methylation densities (number of WTAP-dependent methylation sites normalized by gene length) in mouse, we noted that the top 20% of expressed genes were significantly less likely to be methylated compared to more lowly expressed genes ( Figure 4A ). Indeed, genes completely lacking methylation sites are highly enriched for those involved in ''housekeeping'' cellular processes like translation, mitochondrial-related processes, chromatin regulation, and splicing. To study this further, we examined the proportion of genes lacking methylations across all Gene Ontology (GO) categories in human, mouse, and yeast. This analysis revealed that the functional group ''structural constituents of ribosome'' ranked highest in proportion of genes lacking methylation in both human and mouse, and second highest in yeast ( Figure 4B ). Other groups of housekeeping genes ranking high in both yeast and mammals include splicing and GTPase activity ( Figure 4B ). Thus, lack of methylations among ribosomal proteins, in particular, and specific sets of housekeeping proteins, in general, is conserved between yeast and mammals.
Because housekeeping genes generally have shorter mRNAs with shorter CDSs and UTRs and fewer exons (Eisenberg and Levanon, 2003) and longer RNA half-lives (Schwanhä usser et al., 2011) , we directly examined the correlation between each of these variables and methylation densities ( Figures 4C  and 4D) . Strikingly, the variable correlating most strongly with methylation density was mRNA half-life ( Figures 4C-4E) , as previously estimated in mouse fibroblasts (Schwanhä usser et al., 2011) (Spearman r = À0.27, p = 1.2 3 10 À69 ), and this correlation remained of similar magnitude (r = À0.22) when performing this analysis after eliminating the top 10% or top 20% of genes, ranked by expression levels. Consistently, examining the difference in proportion of variance explained (R 2 ) when predicting methylation densities from all these variables, compared to exclusion of any single one, revealed that mRNA half-life accounted for the greatest difference ( Figure 4D ). We obtained similar results when performing these analyses for human transcripts using transcript stability estimates in human lymphoblastoid cell lines (Duan et al., 2013) (Figures S3A and S3B) , with half-life exhibiting the strongest correlation with methylation density (Figure S3C ), albeit at somewhat reduced levels (r = À0.14, p = 3.4 3 10 À34 ). Our results are consistent with reports implicating methylations in mRNA degradation (Wang et al., 2014a (Wang et al., , 2014b and suggest that m6A methylation may Only sites detected in two or more of the presented samples (columns), with a maximal Peak Over Input score greater than 8, and within genes expressed above the 60 th percentile are shown. Sites were initially clustered into five clusters using k-means, and three of the clusters were subsequently manually merged with existing clusters, based on similarity of characteristics, to yield three clusters (separated by black lines). For visualization purposes, the log 2 (POI) scores were capped at 4.5 and then transformed into Z scores. The internal shRNA identifiers are indicated in parentheses. help set a basal degradation program, and that highly abundant messages might have evolved to maximize their stability by avoiding mRNA methylation.
WTAP-Independent m6A Methylome at the mRNA Cap Studies in the mid-1970s involving bulk analysis of mRNA caps revealed that when the first nucleotide of a transcript is an adenosine this base can be methylated at the N6 position (Furuichi et al., 1975; Keith et al., 1978; Wei et al., 1975) . However, no study to date has been able to resolve which mRNA caps within which messages are methylated. We hypothesized that the consistently observed WTAP-independent peaks enriched near the TSS (Figures 2A, 2E , and 2F) reflect methylations occurring at the cap. Corroborating this hypothesis, we found that 30.5% of the mouse genes expressed above the 60 th percentile with a ''TSS peak'' (i.e., an m6A peak within the first 200 nt) are annotated to begin with an ''A'', compared to only 23% of the genes lacking a peak (Fisher's exact test, p = 2.8 3 10 À13 ), consistent with analyses performed in Dominissini et al. (2012) . Although this enrichment was significant, it did not explain the peaks observed in the remaining $70% of the genes.
We therefore considered the $70% of genes whose RNA transcripts harbored a TSS peak but whose annotated TSS did not contain an ''A'' at the first base. We suspected that many of these cases might reflect limitations of the genomic annotation, as transcription initiation often occurs from a variety of closely spaced positions (Carninci et al., 2006; Ni et al., 2010; Plessy et al., 2010) . We therefore leveraged the fact that our library construction method relies on ligation of adapters to both ends of the captured RNA fragment, such that although each transcript is fragmented ''randomly,'' every transcript should yield some fragment beginning at its 5 0 terminus, resulting in a ''pileup'' of reads beginning at the 5 0 terminus of genes. Thus, these pileups harbor information on the precise transcript initiation sites. Moreover, methylated transcription start sites (mTSSs) should have a high ratio between the size of these pileups in the IP sample compared to the input sample; sites with high ratios should therefore be highly enriched toward harboring an adenosine, as opposed to typical transcription start sites that tend to begin with a guanosine (Carninci et al., 2006) .
To detect methylated transcription start sites (mTSSs), we compared the number of reads stacks beginning at each of the first 50 annotated positions in the transcript in the IP and input samples (Experimental Procedures). We assembled a catalog of 33,714 sites in mouse with evidence of greater than ten reads beginning at a specific site (across all conditions) and assigned each site a fold change corresponding to its enrichment in IP over input. As expected, we found that sites with stronger fold changes were also dramatically more likely to harbor an adenosine either at the detected site or at the position immediately preceding it, with >80% of the sites harboring an adenosine in the bin of most highly enriched sites ( Figure 5A ). (The tendency for adenosines at the position preceding the pileups is likely due to reverse transcriptase drop-off one base prior to the TSS, as supported by several lines of evidence [Supplemental Discussion; Figures S4A and S4B; and below].) Further corroboration of the validity of the detected sites was obtained from an observation of a strong bias toward pyrimidines at position À1 and a discernible TATA box $30 bp upstream of the detected sites, two hallmarks of transcription initiation sites (Carninci et al., 2006) (Figure 5B ).
Our predicted mTSSs also agree well with the results of cap analysis of gene expression (CAGE) data. We performed the above analyses in human (obtaining highly similar results; Figure S4C ) and focused on a subset of 9,757 putatively methylated TSSs (mTSSs) that were independently detected in at least two experiments in A549 cells, exhibiting at least 4-fold enrichment in IP over input and harboring an adenosine at either the position harboring the read stacks or the one preceding it. We compared these sites to CAGE data in A549 cells, obtained from the ENCODE project (Bernstein et al., 2012) . Of the 9,757 sites, 7,255 (74%) were supported by at least two CAGE tags, compared to only 34.6% among an equally sized set of random controls (Fisher's exact test, p < 2.2 3 10 À16 ). To confirm that the positions harboring the adenosines (''adenosine positions'') were the true TSS even when they preceded the observed stacks by one base (''stack position'') (a phenomenon we attribute to RT drop-off), we examined a subset of 4,879 sites in which the adenosine positions preceded the stack positions. Although 80.5% of the ''adenosine positions'' were supported by at least two CAGE tags, only 36.8% of the ''stack positions'' were supported by CAGE data, similar to the 34.5% overlap obtained in the random data set ( Figure 5C ). Moreover, there was a >6-fold increase in the mean number of CAGE tags supporting the ''adenosine positions,'' compared to either the ''stack positions'' or the random positions ( Figure 5D ). Finally, when restricting this analysis to positions other than the first annotated position, these results were essentially identical (data not shown). Together, this confirms that our approach can identify transcription initiation sites at single nucleotide resolution and that mTSSs can be reliably detected also within a large number of positions other than the annotated TSS.
Based on these analyses, we compiled a catalog of putatively methylated transcription start sites (mTSS), comprising all unique adenosine-containing sites enriched >4-fold in at least one condition, encompassing 15,961 sites from 6,454 mouse genes and 12,601 sites from 5,774 human genes (Table S4 ). Many sites-and particularly sites with stronger associated fold changes-were shared across multiple conditions ( Figures S4D-S4F) , and 51% of the above genes in mouse (23% in human) had more than one detected mTSS across all conditions. Limiting this analysis to a single condition, on average 13% of the transcripts had more than one mTSS in both mouse and human (e.g., Shown is the proportion of nonmethylated genes in each category. Only genes expressed >60 th percentile and longer than 500 nt and only GO categories harboring >30 matches genes were considered for this analysis. (C) Correlations (Spearman r, x axis) between different gene attributes (y axis) and methylation density. Transcript half-lives were obtained from Schwanhä usser et al. (2011) . We used only sites defined in A549 cells (Figure 2E) , in protein coding genes longer than 500 nt and expressed above the 60 th quantile, with a maximum POI score >8, with at least 50% increased POI score in nonperturbed cells compared to WTAP-depleted cells, and which were in segments other than the TSS segment. (D) Analysis examining the difference in variability explained (R 2 , x axis) upon elimination of each of the indicated variables from a linear regression model predicting methylation density on the basis of all of them. (E) Association between mRNA half-lives (Schwanhä usser et al., 2011) and methylation densities. Half-lives were binned into ten equally sized bins, and mean methylation densities for each bin were calculated. Error bars represent the SEM. Figures 5E and 5F) . Evaluation of the number of mTSSs found as a function of gene expression revealed that mTSS detection in our data has not reached saturation ( Figures S4G and S4H) , and thus the numbers reported here most likely reflect a lower bound.
To gain insight into the potential role(s) of mTSSs, we examined the extent to which mTSS presence in a gene was associated with gene structure, RNA stability, and translational efficiency features. Because our ability to detect mTSSs is biased toward more highly expressed genes, we used a randomly sampled control data set matching the expression patterns of the mTSS harboring genes (but lacking mTSSs). We found that the presence of mTSS is significantly inversely corre-lated with 5 0 UTR length in both mouse and human (Figures S5A  and S5E ) and positively correlated with translation efficiency (Figures S5A, S5B , and S5F-S5H). However, in contrast to internal methylation, mTSSs were not associated with transcript stability ( Figures S5A and S5B ; see also Supplemental Discussion). These results may suggest that mTSSs and internal methylation sites may differ both in the factor(s) mediating their catalysis, and in their function, with internal sites potentially affecting stability and mTSSs potentially affecting translation. However, because these results are based on comparison between different transcripts, which may vary from each other in other respects that could potentially correlate with mTSS state, they must be interpreted with care. The presence and abundance of the mTSS identified here add an additional unappreciated layer of complexity to the mammalian transcriptome, suggesting that a substantial fraction of transcripts exist in distinct isoforms, differing not only in the location of the TSS but also in its methylation state. It will be crucial to develop experimental methodologies to specifically perturb the methylation state of individual transcripts, and to monitor the impact of such perturbations on various stages of an RNA's life cycle, to conclusively understand the role of mTSSs.
DISCUSSION
The m6A Methylation Landscape RNA methylations offer the potential of dynamically modulating characteristics of an mRNA's life cycle. Such regulation may potentially be applied either in specific conditions, or to specific transcripts, two scenarios that we set out to explore. By mapping methylations across various dynamic systems in human and mouse, we were able to more than triple the number of sites previously identified for either human or mouse (Dominissini et al., 2012; Meyer et al., 2012) , while simultaneously enhancing the resolution of the detected sites, to nearly single-nucleotide level. We found that across the monitored conditions methylations appeared to be largely static, suggesting that the role of m6A in mammals is to a large extent condition independent. These results should best be interpreted with caution, because it is possible that m6a-seq is unable to capture subtle, quantitative differences in the proportion of transcripts methylated at a specific position, which could still be of functional consequence. To better assess the extent to which m6A is quantitative, measurements by orthogonal methods, such as the recently developed SCARLET (Liu et al., 2013) , will be required for a large number of sites.
Although the topology of WTAP-dependent methylations is relatively static across mRNAs, we find that their distribution across genes is not uniform, and that methylations are depleted from abundantly transcribed messages. We moreover find that methylation densities correlate inversely with mRNA half-life. These findings are consistent with recent findings that YTHDF2 binds to methylated mRNAs and decreases messenger stability (Wang et al., 2014a) , and with the fact that transcript half-lives are generally constant across different conditions. Indeed, in DCs, we do not see any change in m6A densities for those $15% of transcripts where degradation rates change dynamically in response to LPS (data not shown). Collectively, our results suggest that internal m6A sites may play a ''basal'' role in controlling the half-lives of the methylated transcripts, and that this role is relatively constant across the different surveyed conditions.
The Multicomponent Methyltransferase Complex
Initial characterization of the mammalian methyltransferase complex revealed that at least two separable complexes (875 and 200 kDa in size) were required for restoring full m6A activity in vitro (Bokar et al., 1994) . Subsequent analysis identified METTL3 as one of the components in the smaller complex (Bokar et al., 1997) . Here, we show that WTAP, KIAA1429, and METTL14 are required for full m6A activity in vivo. The multiunit structure of the m6A methyltransferase is unique with respect to other characterized nucleic acid methyltransferases (Bokar et al., 1994) , and offers the potential for complex regulation. Such is the case in yeast where onset and offset of methylations in meiosis were governed by up/downregulation of different members of this complex at different time points in meiosis (Schwartz et al., 2013) .
Our results regarding WTAP and METTL14 are consistent with recently published results (Liu et al., 2014; Ping et al., 2014; Wang et al., 2014b) , whereas KIAA1429 was not identified by these studies. The physical association of KIAA1429 with the methyltransferase complex is supported by the physical association of Drosophila homologs of KIAA1429 (virilizer) and WTAP (fl[2]d) in the context of female-specific alternative splicing (Granadino et al., 1990) . Moreover, KIAA1429 in human localizes to the nuclear speckles (Horiuchi et al., 2013) , as do METTL3 (Bokar, 2005) and WTAP (Horiuchi et al., 2013; Little et al., 2000) , further supporting their association with each other. We identified another 13 proteins interacting with two or more of the above components. This collection may contain false-positives, and it will therefore be important to experimentally validate them via similar strategies.
The expression patterns of the different methyltransferase components offer important clues about the processes in which they are implicated. The yeast WTAP homolog, Mum2 is expressed in a meiosis-specific manner (Agarwala et al., 2012; Schwartz et al., 2013) and required for proper progression of meiosis (Davis et al., 2001) . In Drosophila, fl(2)d and virilizer are both expressed at highest levels in the ovaries and brain (Robinson et al., 2013) . Analysis of METTL14 expression levels across the Illumina Human Body Map (Farrell et al., 2014) also reveals particularly high levels of expression in testis and ovaries. These observations, combined with previous findings that ALKBH5, an m6A demethylase, is expressed at highest levels in the testis and required for spermatogenesis , suggest that the methyltransferase complex may have an evolutionary conserved role in mammalian gametogenesis. Nonetheless, the ubiquitous expression of mammalian WTAP and KIAA1429 across tissues and ubiquitous presence of m6A suggests that this modification has acquired additional roles in mammals.
Rich Landscape of m6A at the mRNA Cap In higher eukaryotes, but not in yeast, the 5 0 cap structure contains 2 0 -O-ribose methylations at either the first nucleotide or the first and second nucleotide (Wei et al., 1975) . When the first nucleotide of the transcript is an adenosine, this base can be methylated at the N6 position (Furuichi et al., 1975; Keith et al., 1978; Wei et al., 1975) . However, no studies to date have resolved the methylation states of the caps of specific transcripts. Here, we simultaneously measured transcription initiation sites and their methylation status at thousands of sites and found that the transcription initiation landscape is highly complex, with transcript isoforms differing from each other in their methylation states. Our findings that mTSS state at the cap is correlated negatively with 5 0 UTR length and positively with translation efficiencies suggest that the process most likely to be affected by mTSSs is translation. To investigate this more thoroughly, it will be necessary to better understand the enzymatic components involved in cap methylation (Keith et al., 1978) , and to develop targeted methodologies for monitoring and perturbing methylation status at the cap.
The ubiquity of m6A across dramatically different cell types and systems, the conservation of the different components involved in mediating and binding it across most studied systems, and the phenotypes associated with its depletion all suggest a fundamental role in mammalian cell biology. The rich proteomic and transcriptomic resources we provide in this study will help advance our understanding on the function of this epitranscriptomic modification.
EXPERIMENTAL PROCEDURES
Cell Culture Human embryonic kidney 293T cells were transfected with plasmids encoding 3 0 tagged proteins (Table S4) using Lipofectamine 2000 (Life Technologies). Pull-down was performed with anti-HIS (GenScript) or Anti-V5 (Life Technologies) antibodies. siRNAs (Thermo Scientific) were delivered using Lipofectamine RNAiMAX (Life Technologies); shRNAs (Broad RNAi Consortium) were delivered in polybrene supplemented media and selected for 72-96 hr. Details regarding derivation/culturing of HUES9, neural progenitors, mice brain samples, BMDCs, and hTERT immortalized fibroblasts reprogrammed into iPSCs are in Supplemental Experimental Procedures.
Mass Spectrometry Data Analysis
Details pertaining mass spectrometry data acquisition are in Supplemental Experimental Procedures. All mass spectra were processed using the Spectrum Mill software package v4.0 beta (Agilent Technologies) according to (Mertins et al., 2012) . For each peptide, a log2 fold change was calculated between its intensities in the pull-down sample compared to the control. The peptides were mapped to genes based on the Uniprot database, and the median fold change was assigned to each gene. We then subtracted the median of the distribution of the log2 transformed values (across all genes) from the individual fold changes of each gene, to center the fold change distribution around 0. To filter out background contaminants, we used the CRAPOME database (Mellacheruvu et al., 2013) , which summarizes the number of peptides identified for each protein across 343 control experiments. A protein was considered a contaminant if it was present (based on two or more peptides) across R20 control experiments, and filtered from subsequent analysis. We supplemented our data with published proteomics data of WTAP pulldown, obtained from Horiuchi et al. (2013) . Then, we generated a network, whereby a directed edge existed between bait A (METTL3, WTAP, METTL14, YTHDF1, YTHDF2, YTHDF3, or m6A bait) and target B if the interaction between the two, in any of the experiments, was associated with a fold change >1.5.
M6A-Seq and Analysis of Internal m6A Methylation Sites
Isolation of total RNA, preparation of poly(A) RNA, the m6A pull-down procedure, and library preparation were performed as detailed in Schwartz et al. (2013) . The computational analysis for internal sites is based on Schwartz et al. (2013) , with some modifications (Supplemental Experimental Procedures).
Analysis of Putative Sites in the TSS
To identify putative mTSSs, we first counted the number of ''left'' reads originating at the first 50 bp of all annotated transcripts and recorded all positions in which a stack of five or more reads originated. An initial collection of all sites matching these criteria, and identified across any of the perturbations or dynamic systems, was generated. To account for the presumed RT dropoff, each site was assigned an ''effective position,'' which corresponded to the stack position, unless that position did not harbor an adenosine and the position immediately preceding it did, in which case it was assigned the position preceding it. Sites were then aggregated based on genes and effective positions, and for each position we summarized (1) total number of reads orig-inating from all input samples at each effective site, (2) total number of reads from all IP samples, and (3) a fold change between (1) and (2).
Statistical Analysis
All statistical analyses and visualizations were performed in R. Sequence logos were prepared using the SeqLogo package, and heatmaps were generated with the gplots package.
ACCESSION NUMBERS
Sequencing data have been deposited into the NCBI Gene Expression
Omnibus under accession number GSE54365. 
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